94
Participants
Start Date
February 1, 2025
Primary Completion Date
August 1, 2025
Study Completion Date
August 1, 2026
(Daunorubicin, Cytarabine, Venetoclax)
"* Drugs:Daunorubicin~ * Dosage: 40 mg/(m²·d) on days 1 to 3~ * Other names: Cerubidine, Daunomycin, Rubidomycin~* Drugs:Cytarabine~ * Dosage: 100 mg/(m²·d) on days 1 to 5~ * Other names: Ara-C, Cytosine Arabinoside, Cytosar-U~* Drugs:Venetoclax~ * Dosage: 100 mg on day 1, 200 mg on day 2, and 400 mg from days 3 to 14~ * Other names: ABT-199, Venclexta, Venclyxto"
(Daunorubicin, Cytarabine)
"* Drugs:Daunorubicin~ * Dosage: 60 mg/(m²·d) on days 1 to 3~ * Other names: Cerubidine, Daunomycin, Rubidomycin~* Drugs:Cytarabine~ * Dosage: 100 mg/(m²·d) on days 1 to 7~ * Other names: Ara-C, Cytosine Arabinoside, Cytosar-U"
Department of Hematology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei
The First Affiliated Hospital of Anhui Medical University
OTHER
Anhui Medical University
OTHER